Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.822

+2.7%

Nov 18 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hope who wrote (9383)	6/1/1998 12:58:00 PM
From: Scott H. Davis	Read Replies (1) of 14328

OK, here's more feedback. On the plus side, the release spelled out growing business issues (products & distrib channels) & it showed ability to work with FDA again, adding a little hope for HIV. Down side, they did not spell out the $ potential. EBV is not a topic that captures a lot of interest in the market. (also, clinically, I have a disagreement - release made it seem that EBV was sole cause of CFS - NOT!) So VICL announces positive results in cancer application, and market goes for it (up 7.7%) on a down NAZ day. TRIBY releases good news, and is down 2.63%. Market wants to see the $ potential of the news if it does not have a pre-existng idea. Its my opinion based on observating market behavior to TRIBY is that we'll continue to see people selling into news who share the opinion the TRIBY upside is limited rest of 98. Is that enough response? Scott

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next